Welcome, Introduction, SITC Resources
Session I: Introduction to Cancer Immunotherapy
Basic Principles of Cancer ImmunotherapyPamela S. Ohashi, PhD – Princess Margaret Cancer Centre
Session II: Immunotherapy in Practice
Immunotherapy for the Treatment of Skin CancersElaine McWhirter, MD, MSc – Hamilton Health Sciences
Immunotherapy for the Treatment of Lung CancerAdrian G. Sacher, MD, MMSc – Princess Margaret Cancer Center
Immunotherapy for the Treatment of Head and Neck CancersMartin Smoragiewicz, MD.CM, PhD, FRCPC – Sunnybrook Health Sciences Centre
Immunotherapy for the Treatment of Genitourinary MalignanciesAly-Khan Lalani, MD, FRCPC – Hamilton Health Sciences
Immunotherapy for the Treatment of Hematologic MalignanciesStephen Ronan Foley, MD, FRCPC – Hamilton Health Sciences
Immunotherapy for the Treatment of Additional Solid Tumors: Gynecological CancersStephanie Lheureux, MD, PhD – Princess Margaret Cancer Center
Session III: Immunotherapy Challenges and Beyond
Toxicity ManagementMateya Trinkaus, MD – Markham Stouffville Hospital
Practical Barriers in Cancer ImmunotherapyInes Menjak, MD, MSc, FRCPC – Sunnybrook Health Sciences Centre
What's Next for Cancer Immunotherapy?Marcus O. Butler, MD – Princess Margaret Cancer Centre
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs.
Presented by leading and local authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:
The 2019–2020 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
2019-2020 Continuing Education Information
Download PDF Flyer
Participation in these CME-, CPE-, CNE- and MOC-certified online pre-program courses by ACI program attendees is strongly recommended.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org